75644-90-5 Usage
Uses
Used in Pain Management:
DSLET is used as an analgesic agent for the treatment of chronic pain. It binds to opioid receptors in the central nervous system, helping to reduce the perception of pain and providing relief to patients suffering from persistent pain conditions.
Used in Neurological Disorders and Injuries:
DSLET is used as a neuroprotective and neuroregenerative agent for the treatment of neurological disorders and injuries. Its ability to support the health and function of neurons makes it a potentially valuable compound for addressing various neurological conditions and promoting recovery from injuries.
Used in Pharmaceutical Research:
DSLET is used as a subject of ongoing research to explore its potential therapeutic uses. As a synthetic peptide with analgesic, antinociceptive, neuroprotective, and neuroregenerative properties, it holds promise for the development of new treatments for pain management, neurological disorders, and injuries. Further studies are needed to fully understand its mechanisms of action and optimize its therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 75644-90-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,6,4 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 75644-90:
(7*7)+(6*5)+(5*6)+(4*4)+(3*4)+(2*9)+(1*0)=155
155 % 10 = 5
So 75644-90-5 is a valid CAS Registry Number.
InChI:InChI=1/C33H46N6O10/c1-18(2)13-24(32(47)39-28(19(3)41)33(48)49)37-31(46)25(15-20-7-5-4-6-8-20)36-27(43)16-35-30(45)26(17-40)38-29(44)23(34)14-21-9-11-22(42)12-10-21/h4-12,18-19,23-26,28,40-42H,13-17,34H2,1-3H3,(H,35,45)(H,36,43)(H,37,46)(H,38,44)(H,39,47)(H,48,49)/t19-,23+,24+,25+,26-,28+/m1/s1
75644-90-5Relevant academic research and scientific papers
Evidence of the Preferential Involvement of μ Receptors in Analgesia Using Enkephalins Highly Selective for Peripheral μ or δ Receptors
Gacel, Gilles,Fournie-Zaluski, Marie-Claude,Fellion, Etienne,Roques, Bernard P.
, p. 1119 - 1124 (2007/10/02)
In order to study the preferential involvement of μ or δ receptors in the analgesic effects of enkephalins, several peptides which selectively interact with these two kinds of receptors in peripheral organs were synthesized.The inhibitory potency on the e
